Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 237
Filter
1.
Br J Oral Maxillofac Surg ; 58(1): 57-61, 2020 01.
Article in English | MEDLINE | ID: mdl-31718918

ABSTRACT

We aimed to compare the postoperative stability of conventional bimaxillary surgery (with bilateral sagittal split osteotomy) with that of maxillary impaction surgery (with mandibular autorotation without bilateral sagittal split osteotomy) in patients with skeletal class II retrognathia. Patients were assigned to have conventional bimaxillary surgery (conventional group, n=6) or mandibular autorotation (experimental group, n=7). Measurements were made using serial lateral cephalometric radiographs taken immediately preoperatively (T0), immediately postoperatively (T1), and one year later (T2) to assess the variation in operative change (T1-T0) and relapse (T2-T1). There was no significant difference in median (range) surgical change in the anterior movement at point B (conventional group, 4.5 (3.0-11.0) mm; experimental group 4.1 (2.1-6.4) mm). However, there was a significant difference in median (range) surgical posterior movement relapse at point B (conventional group -1.7 (-2.3 to -0.5) mm; experimental group -0.6 (-1.0 to 1.0) mm; p=0.032). Mandibular advancement with mandibular autorotation is therefore a more stable procedure than mandibular advancement with bilateral sagittal split osteotomy in patients with skeletal class II retrognathia.


Subject(s)
Retrognathia , Tooth, Impacted , Cephalometry , Follow-Up Studies , Humans , Mandible , Mandibular Advancement , Maxilla , Osteotomy, Le Fort , Osteotomy, Sagittal Split Ramus , Recurrence
2.
Animal ; 10(1): 163-71, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26677935

ABSTRACT

The objective of this study was to determine if a diet supplemented simultaneously with vitamins C and E would alleviate the negative effects of heat stress, applied between 28 and 42 days of age, on performance, carcass and meat quality traits of broiler chickens. A total of 384 male broiler chickens were assigned to a completely randomized design, with a 2×3 factorial arrangement (diet with or without vitamin supplementation and two ambient temperatures plus a pair-feeding group) and 16 replicates. Chickens were kept in thermoneutral conditions up to 28 days of age. They were then housed in groups of four per cage, in three environmentally controlled chambers: two thermoneutral (22.5 and 22.6°C) and one for heat stress (32°C). Half the chickens were fed a diet supplemented with vitamins C (257 to 288 mg/kg) and E (93 to 109 mg/kg). In the thermoneutral chambers, half of the chickens were pair-fed to heat stressed chickens, receiving each day the average feed intake recorded in the heat stress chamber in the previous day. Meat physical quality analyses were performed on the pectoralis major muscle. No ambient temperature×diet supplementation interaction effects were detected on performance, carcass, or meat quality traits. The supplemented diet resulted in lower growth performance, attributed either to a carry-over effect of the lower initial BW, or to a possible catabolic effect of vitamins C and E when supplemented simultaneously at high levels. Heat stress reduced slaughter and carcass weights, average daily gain and feed intake, and increased feed conversion. Growth performance of pair-fed chickens was similar to that of heat stressed chickens. Exposure to heat stress increased carcass and abdominal fat percentages, but reduced breast, liver and heart percentages. Pair-fed chickens showed the lowest fat percentage and their breast percentage was similar to controls. Heat stress increased meat pH and negatively affected meat color and cooking loss. In pair-fed chickens, meat color was similar to the heat stressed group. Shear force was not influenced by heat stress, but pair-fed chickens showed the tenderest meat. In conclusion, reduction in growth performance and negative changes in meat color in heat stressed chickens were attributed to depression in feed intake, whereas negative changes in body composition, higher meat pH and cooking loss were credited to high ambient temperature per se. Diet supplementation with vitamins C and E as antioxidants did not mitigate any of these negative effects.


Subject(s)
Antioxidants/administration & dosage , Chickens/physiology , Dietary Supplements , Meat/standards , Vitamins/administration & dosage , Animal Husbandry , Animals , Ascorbic Acid/administration & dosage , Body Composition/physiology , Diet , Eating , Heat Stress Disorders/physiopathology , Heat Stress Disorders/veterinary , Hot Temperature , Male , Poultry Diseases/physiopathology , Vitamin E/administration & dosage
3.
Oncogene ; 30(26): 2912-20, 2011 Jun 30.
Article in English | MEDLINE | ID: mdl-21317928

ABSTRACT

E4orf6 is one of the oncogene products of adenovirus, and it also has an important role for transportation of cellular and viral messenger RNA (mRNA) during the late phase of virus infection. We previously revealed that E4orf6 controls the fate of AU-rich element (ARE) containing mRNA by perturbing the chromosome maintenance region 1-dependent export mechanism. Here, we show that E4orf6 stabilizes ARE-mRNA through the region required for its oncogenic activity and ubiquitin E3 ligase assembly. Cells that failed to stabilize ARE-mRNA after HuR knockdown were unable to produce colonies in soft agar, even when E4orf6 was expressed. Furthermore, the stabilized ARE-mRNA induced the transformation of rodent immortalized cells. These findings indicate that stabilized ARE-mRNA is necessary, if not all, for the oncogenic activity of E4orf6 and has the potential to transform cells, at least under a certain condition.


Subject(s)
Adenoviridae/physiology , Cell Transformation, Neoplastic/genetics , RNA Stability/physiology , RNA, Messenger/metabolism , Adenoviridae Infections/complications , Adenoviridae Infections/genetics , Adenovirus E4 Proteins/chemistry , Adenovirus E4 Proteins/metabolism , Adenovirus E4 Proteins/physiology , Animals , Base Composition/genetics , Base Composition/physiology , Cell Transformation, Neoplastic/metabolism , Cells, Cultured , Cytoplasm/metabolism , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Nuclear Proteins , Protein Binding , Protein Interaction Domains and Motifs/physiology , Protein Structure, Secondary/physiology , Protein Transport/genetics , Protein Transport/physiology , RNA Stability/genetics , RNA, Messenger/genetics , RNA-Binding Proteins , Rats , Regulatory Elements, Transcriptional/genetics
4.
AJNR Am J Neuroradiol ; 31(8): 1390-4, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20360344

ABSTRACT

BACKGROUND AND PURPOSE: We have been performing the superselective transarterial infusion of high-dose cisplatin for advanced maxillary cancer since 1998 and the local control rate, disease free survival rate, and organ preservation have improved markedly compared with our former therapy. This study evaluates the effectiveness of superselective transarterial infusion therapy by using high-dose cisplatin on maxillary cancer with orbital invasion. MATERIALS AND METHODS: We treated 23 patients with maxillary cancer by using superselective transarterial infusion therapy with high-dose cisplatin and concomitant radiation therapy for 10 years. Of all patients, 15 showed orbital invasion, with 11 of these tumors fed by both internal maxillary and ophthalmic arteries. In all patients, we performed superselective transarterial infusion therapy via the internal maxillary artery and/or the other feeding branches from the external carotid artery. After the operation, we determined whether a pCR had occurred by checking for the presence of viable cells. In addition, we calculated the overall survival rate, preservation rate of the eyeball, and disease-free survival rate. RESULTS: For all 23 patients, pCR and overall survival rates were 95.7% and 78.4%, respectively. To date, 2 of these patients died of lung metastasis without local recurrence. For the 15 patients with orbital invasion, the respective pCR and disease-free survival rates were 93.3% and 87.5%. Eyeballs were preserved in all patients, and local recurrence occurred in only 1 patient, at the inferior wall of the maxillary sinus (not in the orbit). CONCLUSIONS: Superselective transarterial infusion therapy with high-dose cisplatin remarkably improved the local control rate and disease-free survival rate of maxillary cancer. Even in patients with orbital invasion, a high local control rate was achieved, with preservation of the eyeball, through infusion only into branches of the external carotid artery.


Subject(s)
Antineoplastic Agents/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Cisplatin/administration & dosage , Maxillary Neoplasms/drug therapy , Orbital Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Carotid Artery, External , Combined Modality Therapy , Disease-Free Survival , Dose-Response Relationship, Drug , Female , Humans , Infusions, Intra-Arterial , Male , Maxillary Neoplasms/pathology , Maxillary Neoplasms/radiotherapy , Middle Aged , Neoplasm Invasiveness , Orbital Neoplasms/pathology , Orbital Neoplasms/radiotherapy , Survival Rate
5.
J Acoust Soc Am ; 122(3): EL58, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17927308

ABSTRACT

Automatic threshold detection techniques are described for auditory steady-state response (ASSR) elicited with a sinusoidally amplitude-modulated tone. The reliability and frequency specificity of ASSR are discussed. When applied to awake adults and detected by phase spectral analysis, 40-Hz ASSR threshold patterns closely resemble their corresponding audiograms. However, 40-Hz ASSR is insufficiently reliable for determining hearing thresholds in young children during sleep. On the other hand, 80-Hz ASSR is detected clearly in sleeping children. Moreover, 80-Hz ASSR threshold patterns also closely resemble the corresponding audiograms. Therefore, 80-Hz ASSR appears to be useful for objective audiometry in children.


Subject(s)
Audiometry/methods , Auditory Threshold/physiology , Hearing/physiology , Audiology/methods , Humans , Reproducibility of Results , Sensitivity and Specificity
6.
Oncogene ; 26(8): 1110-21, 2007 Feb 22.
Article in English | MEDLINE | ID: mdl-17146433

ABSTRACT

To identify target genes for the hemizygous deletions of chromosome 13 that are recurrently observed in malignant gliomas, we performed genome-wide DNA copy-number analysis using array-based comparative genomic hybridization and gene expression analysis using an oligonucleotide-array. The response gene to complement 32 (RGC32) at 13q14.11 was identified as a deletion target, and its expression was frequently silenced in glioma cell lines compared with normal brain. Levels of RGC32 mRNA tended to decrease toward higher grades of primary astrocytomas, especially in tumors with mutations of p53. Expression of RGC32 mRNA was dramatically increased by exogenous p53 in a p53-mutant glioma cell line, and also by endogenous p53 in response to DNA damage in p53+/+ colon-cancer cells, but not in isogenic p53-/- cells. Chromatin immunoprecipitation and reporter assays demonstrated binding of endogenous p53 protein to the promoter region of the RGC32 gene, implying p53-dependent transcriptional activity. Transiently and stably overexpressed RGC32 suppressed the growth of glioma cells, probably owing to induction of G2/M arrest. Immunocytochemical analysis revealed a concentration of RGC32 protein at the centrosome during mitosis. RGC32 formed a protein complex with polo-like kinase 1 and was phosphorylated in vitro. These observations implied a novel mechanism by which p53 might negatively regulate cell-cycle progression by way of this newly identified transcriptional target. Our results provide the first evidence that RGC32 might be a possible tumor-suppressor for glioma, that it is directly induced by p53, and that it mediates the arrest of mitotic progression.


Subject(s)
Cell Cycle Proteins/genetics , Chromosomes, Human, Pair 13/genetics , Gene Expression Regulation, Neoplastic , Glioma/genetics , Muscle Proteins/genetics , Nerve Tissue Proteins/genetics , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Proteins/genetics , Cell Cycle Proteins/analysis , Cell Cycle Proteins/metabolism , Cell Division , Chromatin Immunoprecipitation , Chromosome Deletion , DNA Damage , G2 Phase , Gene Deletion , Glioma/chemistry , Humans , Mitosis , Muscle Proteins/analysis , Muscle Proteins/metabolism , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism , Response Elements , Tumor Cells, Cultured , Tumor Suppressor Proteins/analysis , Tumor Suppressor Proteins/metabolism , Polo-Like Kinase 1
7.
J Clin Pathol ; 59(4): 410-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16461807

ABSTRACT

OBJECTIVE: To evaluate the expression of human glucocorticoid receptors (hGRs), such as hGR (4H2), hGR-alpha, and hGR-beta, in non-neoplastic lymphoid follicles and B cell type malignant lymphomas. METHODS: The expression of hGRs in non-neoplastic lymphoid follicles and malignant lymphomas, including diffuse large cell lymphoma, mantle cell lymphoma, and follicular lymphoma, was examined immunohistochemically. HGR (4H2) expression was confirmed by double immunostaining of tissues and in isolated cells from tonsillar germinal centres, and by immunoelectronmicroscopy. RESULTS: In secondary lymphoid follicles of any non-neoplastic diseases--such as chronic tonsillitis, reactive lymphadenitis, and Kimura's disease--the germinal centre cells often expressed hGR (4H2) and hGR-alpha. Double immunocytochemical staining of isolated germinal centre cells showed that the majority of hGR (4H2) positive cells were CD20 positive B cells, and that follicular dendritic cells also expressed hGR. Immunoelectronmicroscopy revealed the presence of nuclear hGR (4H2) in the binucleated follicular dendritic cells and germinal centre cells. The frequency of hGR (4H2) expression in diffuse large B cell lymphoma was higher, that in mantle cell lymphoma was lower, and that in follicular lymphoma was intermediate among the types of malignant lymphoma. The hGR (4H2) expression was less frequent in cases of grade I follicular lymphoma. CONCLUSIONS: There are differences in hGR expression between the germinal centre and the mantle zone in non-neoplastic lymphoid follicles, and differences of hGR (4H2) expression among the types of malignant lymphoma and grades of follicular lymphoma, which probably contribute to the different steroid sensitivities.


Subject(s)
Lymphoma, B-Cell/chemistry , Neoplasm Proteins/analysis , Palatine Tonsil/chemistry , Protein Isoforms/analysis , Receptors, Glucocorticoid/analysis , B-Lymphocytes/chemistry , Case-Control Studies , Cell Count , Dendritic Cells/chemistry , Germinal Center/chemistry , Humans , Immunohistochemistry/methods , Lymphoma/chemistry , Microscopy, Immunoelectron , Palatine Tonsil/ultrastructure , Statistics, Nonparametric
8.
Surg Neurol ; 60(3): 254-9; discussion 259, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12922047

ABSTRACT

BACKGROUND: Craniopharyngioma is a rare neonatal tumor, although it is the most common tumor of the parasellar region in childhood. Only a few cases have been antenatally diagnosed. We report a case of neonatal craniopharyngioma surgically treated after birth and its inferred tumor inception time. CASE DESCRIPTION: A routine ultrasound at 33 weeks of gestation revealed a high echoic mass at the center of the head in this fetus. The baby was delivered normally at 40 weeks with no abnormal appearance of its body surface. Hypotonicity of her lower limbs was observed. The tumor was totally removed uneventfully by an interhemispheric trans-lamina-terminalis approach at 8 months after birth. CONCLUSION: A kinetic study of the tumor showed that tumor inception time was on the 45.6th day of gestation. The present case is the fourth successful resection of neonatal craniopharyngioma. The literature is reviewed.


Subject(s)
Craniopharyngioma , Gestational Age , Pituitary Neoplasms , Craniopharyngioma/diagnostic imaging , Craniopharyngioma/surgery , Female , Humans , Infant , Infant, Newborn , Magnetic Resonance Imaging , Pituitary Neoplasms/diagnostic imaging , Pituitary Neoplasms/surgery , Tomography, X-Ray Computed , Ultrasonography, Prenatal
9.
Clin Exp Immunol ; 131(2): 312-7, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12562394

ABSTRACT

The immunological mechanisms by which respiratory syncytial virus (RSV) contributes to the development of asthma are poorly understood. gammadelta T cells are important in mucosal defence, and may contribute to the establishment of primary immune responses by producing cytokines early during respiratory infections. Thus, we used flow cytometry and intracellular cytokine staining to investigate the expression of interferon (IFN)-gamma and interleukin (IL)-4 by mitogen-stimulated gammadelta T cells from the peripheral blood of 15 hospitalized infants with RSV bronchiolitis, seven rotavirus-infected infants and eight normal controls. gammadelta T cells from RSV-infected infants had a lower proportion of IFN-gamma-producing cells (median, 4.00%; range, 0.58-6.60%) and a slightly but significantly higher proportion of IL-4-producing cells (median, 0.40%; range, 0.13-2.76%) than rotavirus-infected infants (median, 32.10%; range, 14.43-61.21%; P < 0.01, median, 0.00%; range, 0.00-0.00%; P < 0.05) in the acute phase. By contrast, differences in cytokine production by total CD3+ T cells did not differ significantly between patient groups. Thus, reduced IFN-gamma-production by gammadelta T cells in the peripheral blood of RSV-infected infants is accompanied by increased Th2 cytokine production during the acute phase of disease. At follow-up, eight children had recurrent episodes of wheezing. The frequencies of IFN-gamma-producing gammadelta T cells were significantly lower in patients who developed recurrent wheezing (median, 0.65%; range, 0.02-1.75%) than in patients without recurrent wheezing (median, 6.90%; range, 5.25-10.98%; P < 0.005). Cytokine production by gammadelta T cells may therefore be important in the pathogenesis of acute RSV disease, and play a part in the development of recurrent childhood wheezing after bronchilolitis.


Subject(s)
Bronchiolitis, Viral/immunology , Interferon-gamma/biosynthesis , Receptors, Antigen, T-Cell, gamma-delta/blood , Respiratory Syncytial Virus Infections/immunology , T-Lymphocyte Subsets/immunology , Acute Disease , Asthma/immunology , Asthma/virology , CD3 Complex/blood , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Interleukin-4/biosynthesis , Lymphocyte Activation , Male , Recurrence , Respiratory Sounds/immunology
10.
Clin Otolaryngol Allied Sci ; 27(6): 501-4, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12472519

ABSTRACT

The time-course of the recovery of the hearing level after treatment in 90 patients with idiopathic sudden sensorineural hearing loss was examined. The improvement rate calculated relative to the hearing level of the opposite ear was investigated to estimate the hearing recovery. Follow-up audiograms were performed once per week for 1 month after treatment and once per month thereafter. There were two groups that differed with respect to the characteristics of hearing recovery. One group showed an improvement rate of over 50% at 1-2 weeks and a good improvement rate at 3 months after treatment. In the other group, the improvement rate did not reach 50% at 1-2 weeks, and the improvement rate was poor at 3 months after treatment. The patients with improvement rates of over 50% at 1-2 weeks had earlier initial visits and had mild hearing loss, whereas the patients with profound hearing loss had improvement rates under 50% and poor long-term prognosis. We conclude that the improvement rate at 1-2 weeks after treatment predicts the long-term prognosis for recovery of hearing level in patients with sudden sensorineural hearing loss.


Subject(s)
Hearing Loss, Sensorineural/diagnosis , Audiometry, Pure-Tone , Follow-Up Studies , Hearing Loss, Sensorineural/physiopathology , Humans , Prognosis
11.
Spectrochim Acta A Mol Biomol Spectrosc ; 58(8): 1643-56, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12166736

ABSTRACT

Infrared and Raman spectra of 2,5-bis(1,3-dithiol-2-ylidene)-1,3,4,6-tetrathiapentalene (BDT-TTP) and 1,3,4,6-tetrathiapentalene-2,5-dione (TTP-DO) are reported. The vibrational modes of TTP-DO are assigned with the aid of the depolarization ratio of solution Raman spectra, polarized reflection spectra and polarized Raman spectra. A D2h symmetry is assumed for the BDT-TTP molecule and its in-plane fundamental vibrations are assigned with the aid of the polarization ratio and the correlation with TTP-DO, tetrathiafulvalene (TTF), tetramethyltetrathiafulvalene (TMTTF) and bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF). Normal coordinate calculation with a modified internal valence force field was carried out for the in-plane fundamental vibrations of TTP-DO and BDT-TTP. Ab initio calculations of the normal modes of BDT-TTP0 and BDT-TTP+ are compared with the empirical analysis.


Subject(s)
Cyclopentanes/chemistry , Sulfhydryl Compounds/chemistry , Crystallization , Electrochemistry , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman , Vibration
12.
Article in English | MEDLINE | ID: mdl-11891390

ABSTRACT

Acute low-tone hearing loss (ALHL) is a typical type of hearing loss in Ménière's disease and thought to be caused by endolymphatic hydrops in the inner ear. We treated 40 patients with ALHL by administration of the steroid and the early outcome and prognosis of the hearing level was retrospectively evaluated. The prognosis was generally determined within 7-10 days after administration of steroid. High-dose steroid cured some patients who failed to recover with low-dose steroid therapy. Our results showed that steroid is one of the effective therapies for ALHL and supported that etiology of ALHL involves an immune response.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Hearing Loss, Sensorineural/drug therapy , Hearing Loss, Sensorineural/immunology , Acute Disease , Anti-Inflammatory Agents/administration & dosage , Humans , Injections, Intravenous , Predictive Value of Tests , Prognosis , Retrospective Studies , Risk Factors , Steroids , Time Factors , Treatment Outcome
13.
Auris Nasus Larynx ; 28(4): 311-4, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11694374

ABSTRACT

OBJECTIVE: To examine the role of soluble intercellular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1 (sVCAM-1), and soluble E-selectin (sE-selectin) in the pathogenesis of Wegener's granulomatosis (WG) and the values of measuring serum levels of these soluble adhesion molecules for monitoring disease activity during follow-up, a total of 24 serum samples from 16 patients with WG were studied. METHODS: The serum concentrations of soluble adhesion molecules (sICAM-1, sVCAM-1 and sE-selectin) and cytokines (tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6)) of patients with WG were measured by ELISA. RESULTS: The serum levels of sICAM-1 were significantly elevated in active WG and correlated with disease activity. At the time of relapse, a significant increase of sICAM-1 was also observed. The serum levels of TNF-alpha and IL-6 were also significantly elevated in active WG. CONCLUSION: These findings suggest that sICAM-1 plays an important role in the pathogenesis of WG and may be used as an additional parameter of disease activity.


Subject(s)
E-Selectin/blood , Granulomatosis with Polyangiitis/diagnosis , Intercellular Adhesion Molecule-1/blood , Vascular Cell Adhesion Molecule-1/blood , Adult , Aged , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Granulomatosis with Polyangiitis/immunology , Humans , Interleukin-6/blood , Male , Middle Aged , Reference Values , Tumor Necrosis Factor-alpha/metabolism
14.
Biochemistry ; 40(43): 12826-32, 2001 Oct 30.
Article in English | MEDLINE | ID: mdl-11669619

ABSTRACT

To better understand potential roles of conserved Trp457 of the murine inducible nitric oxide synthase oxygenase domain (iNOS(ox); residues 1-498) in maintaining the structural integrity of the (6R)-5,6,7,8-tetrahydrobiopterin (H(4)B) binding site located at the dimer interface and in supporting H(4)B redox activity, we determined crystallographic structures of W457F and W457A mutant iNOS(ox) dimers (residues 66-498). In W457F iNOS(ox), all the important hydrogen-bonding and aromatic stacking interactions that constitute the H(4)B binding site and that bridge the H(4)B and heme sites are preserved. In contrast, the W457A mutation results in rearrangement of the Arg193 side chain, orienting its terminal guanidinium group almost perpendicular to the ring plane of H(4)B. Although Trp457 is not required for dimerization, both Trp457 mutations led to the increased mobility of the N-terminal H(4)B binding segment (Ser112-Met114), which might indicate reduced stability of the Trp457 mutant dimers. The Trp457 mutant structures show decreased pi-stacking with bound pterin when the wild-type pi-stacking Trp457 position is occupied with the smaller Phe457 in W457F or positive Arg193 in W457A. The reduced pterin pi-stacking in these mutant structures, relative to that in the wild-type, implies stabilization of reduced H(4)B and destabilization of the pterin radical, consequently slowing electron transfer to the heme ferrous-dioxy (Fe(II)O(2)) species during catalysis. These crystal structures therefore aid elucidation of the roles and importance of conserved Trp457 in maintaining the structural integrity of the H(4)B binding site and of H(4)B-bound dimers, and in influencing the rate of electron transfer between H(4)B and heme in NOS catalysis.


Subject(s)
Biopterins/analogs & derivatives , Biopterins/chemistry , Biopterins/genetics , Nitric Oxide Synthase/chemistry , Nitric Oxide Synthase/physiology , Tryptophan/chemistry , Animals , Binding Sites , Catalysis , Conserved Sequence , Crystallography, X-Ray , Dimerization , Electron Transport , Escherichia coli/metabolism , Heme/chemistry , Hydrogen Bonding , Mice , Models, Chemical , Models, Molecular , Mutation , Nitric Oxide Synthase Type II , Protein Binding , Recombinant Proteins/chemistry
15.
Cancer Genet Cytogenet ; 130(1): 38-41, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11672772

ABSTRACT

It has been shown that some cases of B-cell non-Hodgkin lymphoma associated with a hemophagocytic syndrome (B-LAHS) have chromosomal abnormalities at 14q32 or 19q13. We report here a 64-year-old woman with B-LAHS and a complex karyotype including add(14)(q32). We applied spectral karyotyping and revealed that the add(14)(q32) was derived from a der(14)t(14;19)(q32;q13). However, rearrangement of the BCL3 gene at 19q13 could not be detected by Southern blot analysis. Our results indicate that the translocation involving 19q13 may be one of the recurrent aberrations in B-LAHS and that the molecular mechanism of t(14;19)(q32;q13) in B-LAHS appear to be different from that observed in chronic lymphocytic leukemia.


Subject(s)
CD5 Antigens/immunology , Gene Rearrangement , Histiocytosis, Non-Langerhans-Cell/complications , Lymphoma, B-Cell/genetics , Proto-Oncogene Proteins/genetics , Translocation, Genetic , B-Cell Lymphoma 3 Protein , Female , Humans , Karyotyping , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/immunology , Middle Aged , Pregnancy , Transcription Factors
16.
Nihon Rinsho ; 59(7): 1259-63, 2001 Jul.
Article in Japanese | MEDLINE | ID: mdl-11494534

ABSTRACT

The mechanism by which Hepatitis C virus(HCV) infection promotes the development of hepatocellular carcinoma(HCC) is not known exactly. HCV related HCC occurs frequency in the patients with cirrhosis. There have been reports indicating that Th2-type cytokines down-regulated antitumor immunity, and the activation of type 1 T cell responses produced antitumor immunity. We thought Th1/Th2 imbalance in HCV-related liver cirrhosis might be closely related to the development of HCC. In this study, therefore, we investigated the Th1/Th2 balance at the single lymphocyte level of the patients with HCV-related liver cirrhosis and compared with normal controls by using flow cytometry. Th1-type cytokines(IFN-gamma, IL-2) production was significantly decreased in patients with cirrhosis, whereas Th2-type cytokine production(IL-10) was increased. These suggest Th1/Th2 imbalance in HCV-related cirrhosis would decrease the antitumor immunity and its improvement might present the protective effect from HCC.


Subject(s)
Carcinoma, Hepatocellular/immunology , Hepacivirus , Liver Cirrhosis/immunology , Liver Cirrhosis/virology , Liver Neoplasms/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Carcinoma, Hepatocellular/virology , Cytokines/metabolism , Humans , Liver Neoplasms/virology
17.
J Laryngol Otol ; 115(7): 596-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11485601

ABSTRACT

An extremely rare case of primary non-Hodgkin's lymphoma of the larynx (Stage IE) diagnosed by gene rearrangement is reported. The patient was a 76-year-old man with a chief complaint of pharyngeal discomfort. Remission was obtained by excision of the tumour and radiotherapy. Surface phenotypic studies of the laryngeal lesion demonstrated a main population of B-cells expressing L-26, some of the atypical lymphocytes positive with UCHL-1. Genotypic analysis of the specimen disclosed a clonal rearrangement of the immunoglobulin heavy chain with the same rearrangement pattern. These data indicate that this patient had non-Hodgkin's lymphoma with diffuse large B-cell type. Gene rearrangement analysis was useful for diagnosis. Diagnostic and therapeutic options are discussed in light of the current literature.


Subject(s)
Gene Rearrangement , Laryngeal Neoplasms/diagnosis , Lymphoma, B-Cell/diagnosis , Lymphoma, Large B-Cell, Diffuse/diagnosis , Aged , Follow-Up Studies , Humans , Laryngeal Neoplasms/genetics , Lymphoma, B-Cell/genetics , Lymphoma, Large B-Cell, Diffuse/genetics , Male , Polymerase Chain Reaction
18.
J Neurooncol ; 52(1): 23-36, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11451200

ABSTRACT

Most tumors, including gliomas, are resistant to tumor necrosis factor (TNF) cytotoxicity unless protein or RNA synthesis is inhibited. We investigated the effects of the combined use of TNF-alpha and cisplatin (CDDP) on cultured malignant glioma cells, T98G, U373MG, A172, and U87MG. All glioma cell lines were sensitive to treatment with CDDP but resistant to TNF-alpha during 24 h-incubation. The combined use of CDDP and TNF-alpha had synergistic effects on T98G and U87MG but not on U373MG and A172 cells. Sequential treatments showed that only pretreatment with CDDP for 2 h followed by TNF-alpha for 22 h was synergistic on cell cytotoxicity. Annexin V-flow cytometry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling assay showed that TNF-alpha can induce apoptosis in cells treated with CDDP. Although only sensitive cell lines express transcripts for p75 TNF receptor 2, changes in TNF receptors were not found to contribute to the susceptibility to TNF-alpha. The production of interleukin-6, a representative cytoprotective cytokine, from glioma cells stimulated by TNF-alpha was suppressed by the combined use of actinomycin D, but not CDDP. Our results indicate that CDDP can sensitize glioma cells to TNF-alpha-induced apoptosis by a mechanism other than blocking the cytoprotective protein production.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Cisplatin/pharmacology , Glioma/physiopathology , Tumor Necrosis Factor-alpha/pharmacology , Drug Synergism , Humans , Interleukin-6/biosynthesis , Receptors, Tumor Necrosis Factor/metabolism , Tumor Cells, Cultured
19.
J Gastroenterol ; 36(5): 350-3, 2001 May.
Article in English | MEDLINE | ID: mdl-11388400

ABSTRACT

Fulminant hepatic failure (FHF) usually has a fatal prognosis without liver transplantation. We describe the case of a woman who developed FHF, and was evaluated as a candidate for liver transplantation, but who was cured without transplantation through intensive medical care that included glucagon-insulin therapy, methylprednisolone pulse therapy, interferon beta and lamivudine administration, cyclosporine administration, and high-volume hemodiafiltration and plasma exchange. In a patient with FHF who is a candidate for liver transplantation but for whom the transplantation cannot be performed for some reason, intensive medical therapy, including regeneration-promoting therapy, immunosuppressive therapy, antiviral therapy, and vigorous hepatic support, should be carried out.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis B/complications , Liver Failure/therapy , Cyclosporine/therapeutic use , Female , Hemodiafiltration/methods , Humans , Interferon-beta/therapeutic use , Liver Failure/diagnosis , Liver Failure/virology , Liver Transplantation , Methylprednisolone/therapeutic use , Middle Aged , Plasma Exchange/methods
20.
Clin Neurol Neurosurg ; 103(1): 13-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11311470

ABSTRACT

We investigated the expression of c-myc and c-sis/PDGF mRNA and protein products in 20 cases of meningiomas of various grades: 10 benign, 5 atypical and 5 anaplastic meningiomas. All cases of atypical and anaplastic meningiomas were positive for c-myc protein and mRNA by immunohistochemistry and in situ hybridisation, respectively, while all 10 benign meningiomas were negative for c-myc immunostaining, with only one benign tumour positive for c-myc mRNA. Expression of PDGF-BB protein and c-sis mRNA were seen in more than 80% of the meningioma cases and was not restricted to the histological grades of meningiomas. Semiquantitative analysis showed that the frequency of c-myc immunopositive cells positively correlated with Ki-67 proliferative indices. Our findings suggest that c-myc, but not c-sis/PDGF, has some concern to the malignancy of meningiomas.


Subject(s)
Gene Expression Regulation, Neoplastic , Meningeal Neoplasms/pathology , Meningioma/pathology , Neoplasm Proteins/analysis , Phosphoproteins/analysis , Proto-Oncogene Proteins c-myc/analysis , Proto-Oncogene Proteins c-sis/analysis , Adult , Female , Humans , Immunohistochemistry , In Situ Hybridization , Male , Meningeal Neoplasms/chemistry , Meningeal Neoplasms/classification , Meningeal Neoplasms/genetics , Meningioma/chemistry , Meningioma/classification , Meningioma/genetics , Middle Aged , Neoplasm Proteins/genetics , Phosphoproteins/genetics , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-sis/genetics , RNA, Messenger/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...